8-KLeadership ChangesShareholder MattersExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Executive Changes (Apr 30, 2025)

Filed April 30, 2025For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed an 8-K on April 29, 2025, reporting on the company's 2025 Annual Meeting of Shareholders held on April 24, 2025. The report details the outcomes of various shareholder votes, including the election of all 11 director nominees and the advisory approval of executive compensation. Notably, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025 was ratified. The filing also announced the upcoming retirement of board member D. Adamczyk, effective May 31, 2025, due to his decision to join Goldman Sachs as a Partner. This departure is stated to be for personal reasons and not a result of any disagreement with the company's management.

Key Highlights

  • 1All 11 director nominees were elected to the Board of Directors, indicating strong shareholder confidence in current leadership.
  • 2Shareholders approved, on an advisory basis, the company's executive compensation ("Say on Pay"), signifying support for the compensation philosophy.
  • 3PricewaterhouseCoopers LLP was ratified as JNJ's independent auditor for fiscal year 2025, a routine but important vote for financial integrity.
  • 4D. Adamczyk will retire from the Board of Directors effective May 31, 2025, to pursue a role as a Partner at Goldman Sachs.
  • 5The shareholder proposal seeking a vote on excessive golden parachutes was not approved, with a significant majority voting against it.
  • 6The shareholder proposal requesting a human rights impact assessment was also not approved by the majority of shareholders.

Frequently Asked Questions